Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Depressive Disorders: Etiology

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

Anxiety: Overview

Anxiety: Overview

Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.

Generalized Anxiety Disorder

Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...

Panic Disorder

Panic Disorder

Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Molecular basis of CXC chemokine receptor 3 ligand multispecificity.

Science advances·2026

Same author

Lymphadenopathy: Evaluation and Differential Diagnosis.

American family physician·2025

Same author

Effects of chemotherapy on skeletal muscle mitochondrial oxidative capacity using near-infrared spectroscopy (NIRS): Protocol paper for an observational mixed model repeated measures design in patients with breast and gynecological cancer.

PloS one·2025

Same author

A Case of Necrotizing Lymphadenitis From Streptococcus pyogenes.

Cureus·2025

Same author

Frontal damage and resolution of schizophrenia in a patient with self-inflicted gunshot wound: a case report.

BMC neurology·2025

Same author

Impact of Time in Therapeutic Range on Adverse Events in Atrial Fibrillation Patients in an Ambulatory Care Setting.

Hospital pharmacy·2024

Search research articles

Related Experiment Video

Updated: Aug 3, 2025

A New Method for Inducing a Depression-Like Behavior in Rats

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

Mood and Anxiety Disorders: Major Depressive Disorder.

Ashley Falk¹, Rosa Joseph¹, Shannon Smith²

¹Department of Family Medicine and Rural Health - Florida State University College of Medicine, 1115 West Call St, Tallahassee, FL 32306.

|April 10, 2023

Summary

Major Depressive Disorder (MDD) diagnosis requires specific symptoms, including depressed mood or loss of interest. Screening in adults is advised when resources permit, utilizing tools like the PHQ-9.

More Related Videos

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

Related Experiment Videos

Last Updated: Aug 3, 2025

A New Method for Inducing a Depression-Like Behavior in Rats

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

Area of Science:

Psychiatry
Clinical Psychology
General Medicine

Background:

Major Depressive Disorder (MDD) is a prevalent mental health condition characterized by a cluster of specific symptoms.
Early identification and intervention are crucial for managing MDD and preventing long-term consequences.

Purpose of the Study:

To outline the diagnostic criteria for Major Depressive Disorder (MDD).
To recommend screening protocols for MDD in the general adult population.
To describe available screening tools and management strategies for MDD.

Main Methods:

Diagnostic criteria for MDD involve at least five symptoms, including depressed mood or anhedonia, over a two-week period.
Screening for MDD is recommended in adults when diagnostic and treatment resources are available.
Validated screening tools such as the Patient Health Questionnaire-9 (PHQ-9) and Beck Depression Inventory for Primary Care (BDI-PC) can be utilized.

Main Results:

MDD diagnosis requires specific symptom constellations, with at least one core symptom being depressed mood or loss of interest/pleasure.
Screening tools like PHQ-9 and BDI-PC aid in identifying potential MDD cases.
Laboratory tests can help rule out comorbidities or contraindications to treatment.

Conclusions:

MDD screening is recommended for adults when follow-up care is accessible.
Management strategies include psychotherapy and pharmacotherapy, with selective serotonin reuptake inhibitors being common.
Treatment duration of 16-24 weeks is advised to prevent recurrence, with specialist referral considered for complex cases.